Given that ERG is a direct target of IKAROS and is strongly repressed upon IK1 re-expression, we next tested whether ERG contributes to leukemic maintenance in IKZF1-deficient B-ALL. The gene discussed is IKZF1; the disease is acute lymphoblastic leukemia.